微生态制剂对新生儿高胆红素血症的预防作用

Probiotics Protection Against Neonatal Hyperbilirubinemia

目的:探讨微生态制剂对新生儿高胆红素血症的预防作用。方法:选取足月新生儿224例,通过随机分组方式,干预组109例和对照组115例,出生后12h内干预组给予口服微生态制剂双歧四联活菌片,对照组无干预措施。结果:新生儿高胆红素血症的发生率方面比较,干预组为13.76%;对照组为28.70%,干预组的发生率较对照组低(P<0.05)。结论:口服微生态制剂双歧四联活菌片对新生儿高胆红素血症有一定的预防作用。

Objective： To investigate the preventive effects of probiotics on neonatal hyperbilirubinemia. Methods： A total of 224 cases of full-term newborns, by randomly, intervention group（109 cases） and the control group（115 cases）, within 12 hours after birth in the intervention group received oral micro ecological preparation of Bifidobacterium quadruple live bacteria tablets and control group without intervention. Results： Incidence of neonatal hyperbilirubinemia rate, intervention group was 13.76%; is 28.70% in the control group, the intervention group occurrence rate is lower than the control group（P〈0.05）. Conclusion： Oral probiotics Bifidobacterium Tetravaccine tablets have a certain preventive effect on neonatal hyperbilirubinemia.